HMPV is surging in China. Is the US next?
Advisory Board January 8, 2025
COVID-19 Upends Business-as-usual Research and Regulatory Practices
Pharmaceutical Executive March 16, 2020
Now officially a worldwide pandemic, the biomedical research community is rushing to develop treatments and preventives to halt the spread and severity of the COVID-19 virus. Political infighting has stymied an effective response in the US, with much finger-pointing on all sides. As the severity of the disease becomes more starkly apparent, schools and communities have shut down and cancellations have hit most travel, sports, and business and professional meetings.
An efficient effort by the US health care system to identify and isolate infected individuals has been undermined by a lack of fast and available diagnostics, and remedies have been derailed by political missteps and administrative failings. Short supplies of test kits and of reagents have forced clinics and hospitals...
Today's Sponsors
Today's Sponsor